Literature DB >> 19362523

Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD.

V Nobili1, A Reale, A Alisi, G Morino, I Trenta, M Pisani, M Marcellini, U Raucci.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease, ranging from hepatic steatosis to necro-inflammation with or without fibrosis (non-alcoholic steatohepatitis), is a growing clinical liver disorder in children. AIM: The goals of this study were to characterize liver disorders associated with elevated aminotransferases and establish the non-alcoholic fatty liver disease/non-alcoholic steatohepatitis prevalence in hypertransaminasemic children admitted to the emergency room.
METHODS: The medical records of 3280 children (2-17 years of age) admitted to the emergency room of Bambino Gesù Children's Hospital of Rome, and presenting with hypertransaminasemia were analysed retrospectively.
RESULTS: Elevation of serum alanine aminotransferases was present in 897 patients. Of these, 520 (58%) spontaneously normalized alanine aminotransferases, and 179/897 (20%) maintained persistently elevated alanine aminotransferases levels. Twenty-one patients were excluded because of medication or alcohol use. In the remaining 157 patients with elevated alanine aminotransferases, obesity was found in 87 (55%), viral infections in 52 (33%) and genetic diseases in 14 (9%). Obesity-related alanine aminotransferases elevation was associated with a histological diagnosis of non-alcoholic fatty liver disease in 85% of patients. In particular, steatosis was histologically confirmed in 74 patients; 43/74 (58%) had steatohepatitis, and 12/74 (16%) had fibrosis.
CONCLUSIONS: Twenty percent of children with elevated aminotransferases on routine testing may hide non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. A careful diagnostic workup of persistent hypertransaminasemia in all obese subjects is warranted in the paediatric setting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362523     DOI: 10.1016/j.dld.2009.02.048

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  16 in total

1.  The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy.

Authors:  Raquel M S Campos; Aline de Piano; Patrícia L da Silva; June Carnier; Priscila L Sanches; Flávia C Corgosinho; Deborah C L Masquio; Marise Lazaretti-Castro; Lila M Oyama; Cláudia M O Nascimento; Lian Tock; Marco Túlio de Mello; Sergio Tufik; Ana R Dâmaso
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

Review 2.  Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

Authors:  Anna Alisi; Ariel E Feldstein; Alberto Villani; Massimiliano Raponi; Valerio Nobili
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-17       Impact factor: 46.802

3.  Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention.

Authors:  Valerio Nobili; Anna Alisi; Massimiliano Raponi
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

Review 4.  Pediatric non-alcoholic fatty liver disease: New insights and future directions.

Authors:  Pierluigi Marzuillo; Emanuele Miraglia Del Giudice; Nicola Santoro
Journal:  World J Hepatol       Date:  2014-04-27

Review 5.  Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.

Authors:  Pierluigi Marzuillo; Anna Grandone; Laura Perrone; Emanuele Miraglia Del Giudice
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

6.  The triglycerides and glucose index is strongly associated with hepatic steatosis in children with overweight or obesity.

Authors:  Luis E Simental-Mendía; César Javier Ortega-Pacheco; Elvira García-Guerrero; María Alejandra Sicsik-Aragón; Fernando Guerrero-Romero; Gerardo Martínez-Aguilar
Journal:  Eur J Pediatr       Date:  2021-01-25       Impact factor: 3.183

Review 7.  Pediatric fatty liver disease: role of ethnicity and genetics.

Authors:  Pierluigi Marzuillo; Emanuele Miraglia del Giudice; Nicola Santoro
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 8.  Persistent hypertransaminasemia in asymptomatic children: a stepwise approach.

Authors:  Pietro Vajro; Sergio Maddaluno; Claudio Veropalumbo
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

9.  The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice.

Authors:  Earl Kim; Yunkoo Kang; Seungmin Hahn; Mi Jung Lee; Young Nyun Park; Hong Koh
Journal:  Korean J Pediatr       Date:  2013-01-29

Review 10.  Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets.

Authors:  Valentina Giorgio; Federica Prono; Francesca Graziano; Valerio Nobili
Journal:  BMC Pediatr       Date:  2013-03-25       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.